Qing-Xin-Jie-Yu Granule attenuated post-heart attack inflammation by regulating the MK2/TTP pathway in both mouse models and cell cultures.
MK2/TTP pathwayIdentified molecular mechanism for QXJYG's anti-inflammatory cardioprotective effects
What the researchers found
QXJYG reduced post-MI inflammation and improved cardiac function by modulating the MK2/TTP anti-inflammatory pathway.
Why it matters
Understanding the molecular mechanisms of traditional medicines can validate their use and potentially lead to new drug targets.
The numbers in context
Mouse MI model (LAD ligation); improved echocardiographic function; reduced serum injury markers; modulated MK2/TTP pathway proteins in vivo and in vitro.
How the study worked
Mouse MI model (LAD ligation), in vitro hypoxic H9C2 cells, echocardiography, histology, ELISA, and pathway analysis.
Who was studied
Mice with induced myocardial infarction; H9C2 cardiomyocytes
What this study cannot tell us
Mouse model and cell culture — human clinical trial data for this specific indication is needed. TCM formulation standardization varies.
How to read the evidence
Preclinical study with clear mechanism — strong in mice but requires human validation.
When this study was published
Published in 2025, contributing mechanistic evidence for traditional Chinese medicine in cardiology.
The bigger picture
Bridging traditional Chinese medicine with modern molecular pharmacology validates ancient practices and identifies actionable drug targets.
Questions still open
- Could MK2/TTP-targeting drugs replicate QXJYG's benefits?
- Has QXJYG been tested in human MI patients?
Common questions
Can traditional Chinese medicine help after a heart attack?
What is the MK2/TTP pathway?
Read the original research
Qing-Xin-Jie-Yu Granule attenuates myocardial infarction-induced inflammatory response by regulating the MK2/TTP pathway.
Pharmaceutical biology, 63(1), 128-140
Citation
Qi, Jianghan; Gao, Xiaoyao; Han, Ying; Yang, Meiling; Wei, Chenyi; Zhang, Ling; Chu, Jianfeng. (2025). Qing-Xin-Jie-Yu Granule attenuates myocardial infarction-induced inflammatory response by regulating the MK2/TTP pathway.. Pharmaceutical biology, 63(1), 128-140. https://doi.org/10.1080/13880209.2025.2467377